Suppr超能文献

倍他米松停用所致无痛性甲状腺炎

Painless thyroiditis induced by the cessation of betamethasone.

作者信息

Morita S, Ueda Y, Yokoyama N

机构信息

Internal Medicine, Japanese Red Cross-Nagasaki Atomic Bomb Hospital.

出版信息

Intern Med. 2001 Aug;40(8):744-6. doi: 10.2169/internalmedicine.40.744.

Abstract

We describe the first reported case of painless thyroiditis induced by an abrupt cessation of betamethasone. A 53-year-old woman experienced transient thyrotoxicosis after the abrupt cessation of celestamine, a mixture of betamethasone and chlorpheniramine. Since neither TSH receptor- nor thyroid stimulating-antibodies were negative, and thyroid scintigram did not show the thyroid gland, she was diagnosed as having painless thyroiditis. Fourteen months after the onset of thyrotoxicosis, serum TSH was detectable without hypothyroidism. We speculate that reduction in betamethasone may be one of the triggers of painless thyroiditis.

摘要

我们报告了首例因突然停用倍他米松引发无痛性甲状腺炎的病例。一名53岁女性在突然停用含倍他米松和氯苯那敏的复方制剂(仙特明)后出现短暂甲状腺毒症。由于促甲状腺激素受体抗体和促甲状腺激素均为阴性,且甲状腺闪烁扫描未显示甲状腺,她被诊断为无痛性甲状腺炎。甲状腺毒症发作14个月后,血清促甲状腺激素可检测到,且无甲状腺功能减退。我们推测倍他米松减量可能是无痛性甲状腺炎的触发因素之一。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验